Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation

Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation at other companies

Zymeworks logo
ZymeworksZYME
——

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation?
BioCryst Pharmaceuticals (BCRX) reported share-based payment arrangement, decrease for tax withholding obligation of $56K in Q1 2025.
How has BioCryst Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation changed year-over-year?
BioCryst Pharmaceuticals's share-based payment arrangement, decrease for tax withholding obligation increased by 47.4% year-over-year, from $38K to $56K.
What does share-based payment arrangement, decrease for tax withholding obligation mean?
Reflects the cash outflow or reduction in equity resulting from the company withholding shares to satisfy statutory tax obligations on behalf of employees upon the vesting of equity awards. This provides insight into the tax-related cash flow impacts of share-based compensation programs.